Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Moodys
Deloitte
Fuji
Healthtrust
US Department of Justice
Johnson and Johnson
Queensland Health
Federal Trade Commission
Novartis
Merck

Generated: August 17, 2017

DrugPatentWatch Database Preview

AMIKIN Drug Profile

« Back to Dashboard

Which patents cover Amikin, and when can generic versions of Amikin launch?

Amikin is a drug marketed by Apothecon and is included in four NDAs.

The generic ingredient in AMIKIN is amikacin sulfate. There are fifteen drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the amikacin sulfate profile page.

Summary for Tradename: AMIKIN

Patents:0
Applicants:1
NDAs:4
Bulk Api Vendors: see list64
Clinical Trials: see list1
Patent Applications: see list6,285
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:AMIKIN at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apothecon
AMIKIN
amikacin sulfate
INJECTABLE;INJECTION062311-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Apothecon
AMIKIN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
amikacin sulfate
INJECTABLE;INJECTION050618-002Nov 30, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe
Apothecon
AMIKIN
amikacin sulfate
INJECTABLE;INJECTION062562-002Sep 20, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe
Apothecon
AMIKIN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
amikacin sulfate
INJECTABLE;INJECTION050618-001Nov 30, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe
Apothecon
AMIKIN
amikacin sulfate
INJECTABLE;INJECTION062311-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Merck
AstraZeneca
Cipla
Chinese Patent Office
Johnson and Johnson
Citi
US Army
McKinsey
Argus Health
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot